CD274 and neoplasm: PD-L1 protein expression in the tumor cell component was present in 43/561 (7.7%) and 77/452 (17%) of the Yale and UM cohorts and stromal PD-L1 protein expression was detectable in 55/561 (9.8%) and 61/449 (13.6%) of the Yale and UM cohorts, respectively.